Gene · 839
Papers3,659
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,659
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug Development from Natural Products Based on the Pathogenic Mechanism of Asthma. | Int J Mol Sci | 2023 | 37569846 | PubTator, text mining | PubMed |
| Exploring the Role of Hsp60 in Alzheimer's Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting. | Int J Mol Sci | 2023 | 37569831 | PubTator, text mining | PubMed |
| Different Impacts of Cryopreservation in Endothelial and Epithelial Ovarian Cells. | Int J Mol Sci | 2023 | 37569601 | PubTator, text mining | PubMed |
| Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37569254 | PubTator, text mining | PubMed |
| A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma. | Aging (Albany NY) | 2023 | 37561524 | PubTator, text mining | PubMed |
| Effects of perchlorate and exogenous T4 on growth, development and tail resorption of Rana chensinensis. | Environ Pollut | 2023 | 37558196 | PubTator, text mining | PubMed |
| Multi-Omics Analysis Elucidates The Immune And Intratumor Microbes Characteristics Of Ubiquitination Subtypes In Lung Adenocarcinoma. | Transl Oncol | 2023 | 37549605 | PubTator, text mining | PubMed |
| Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy. | Mol Ther Nucleic Acids | 2023 | 37547288 | PubTator, text mining | PubMed |
| Viral protein R (Vpr)-induced neuroinflammation and its potential contribution to neuronal dysfunction: a scoping review. | BMC Infect Dis | 2023 | 37545000 | PubTator, text mining | PubMed |
| Knockdown of ANLN inhibits the progression of lung adenocarcinoma via pyroptosis activation. | Mol Med Rep | 2023 | 37539739 | PubTator, text mining | PubMed |
| PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer. | Front Oncol | 2023 | 37519797 | PubTator, text mining | PubMed |
| Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution? | Viruses | 2023 | 37515138 | PubTator, text mining | PubMed |
| Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells. | Metabolites | 2023 | 37512503 | PubTator, text mining | PubMed |
| Bridging Pyroptosis and Immunity: A Comprehensive Study of the Pyroptosis-Related Long Non-Coding RNA Signature in Breast Cancer. | Life (Basel) | 2023 | 37511974 | PubTator, text mining | PubMed |
| Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition. | Foods | 2023 | 37509754 | PubTator, text mining | PubMed |
| The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas. | Front Mol Neurosci | 2023 | 37501725 | PubTator, text mining | PubMed |
| Eurycoma longifolia: an overview on the pharmacological properties for the treatment of common cancer. | J Public Health Afr | 2023 | 37492537 | PubTator, text mining | PubMed |
| In silico identification and in vitro assessment of a potential anti-breast cancer activity of antimicrobial peptide retrieved from the ATMP1 Anabas testudineus fish peptide. | PeerJ | 2023 | 37483971 | PubTator, text mining | PubMed |
| Resveratrol triggers the ER stress-mediated intrinsic apoptosis of neuroblastoma cells coupled with suppression of Rho-dependent migration and consequently prolongs mouse survival. | Chem Biol Interact | 2023 | 37482209 | PubTator, text mining | PubMed |
| Identification of pyroptosis-related genes and potential drugs in diabetic nephropathy. | J Transl Med | 2023 | 37480090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/839/papers?page=11